Skip to content

AI Quantitative Coronary Angiography Versus Optical Coherent Tomography Guidance for Coronary Stent Implantation

Fully Automated Quantitative Coronary Angiography Versus Optical Coherent Tomography Guidance for Coronary Stent Implantation (FLASH): Multicenter, Randomized Controlled Non-Interiority Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05388357
Acronym
FLASH
Enrollment
400
Registered
2022-05-24
Start date
2022-10-04
Completion date
2024-10-02
Last updated
2024-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Vessels, Procedure PCI

Keywords

OCT, AI ,PCI

Brief summary

This study is to establish the primary hypothesis thatAI -QCA guided PCI is non-inferior to Optical coherence tomography-guided Percutaneous coronary intervention regarding minimal Stent area by Final OCT and Procedural MACE

Detailed description

1. AI-QCA-assisted DES implantation After coronary angiography, AI-QCA software will be used to determine the lesion length and the reference vessel diameter in real time to determine the appropriate stent size for implantation. The procedure is performed as follows: 1. Select the optimal projection angle providing the best view of the lesion. 2. Provide sufficient nitroglycerin for vasodilation. If the lesion is severely stenotic, perform balloon angioplasty, followed by nitroglycerin supply. 3. Perform AI-QCA to measure the length of the lesion and the inside diameter of the proximal and distal reference vessels. 4. Determine the stent length and size according to the AI-QCA measurements. Select a stent that is 20% larger than the distal reference vessel diameter and that can provide coverage for both the proximal and distal reference vessels. 5. Perform high-pressure balloon dilation after stent implantation, with the final balloon size being 20% larger than the distal and proximal reference vessel diameters. 6. Perform a final coronary angiogram if no procedural complications are observed on the angiogram and stent expansion is confirmed. 7. Perform a final OCT to measure the stent area (mm2), the primary efficacy endpoint. 8. If significant suboptimal stent results, such as severe underexpansion, extensive strut malapposition, or major stent edge dissection, occur, additional procedures to correct them are permitted to ensure patient safety, although they are generally discouraged. (The primary endpoint will be assessed by OCT run before such correction.) 2. OCT guided DES implantation After coronary angiography, OCT is performed to determine the appropriate stent size for implantation. After the stent procedure, OCT is performed again to check for an area that is smaller than the area of distal reference vessel and for sufficient dilatation. If necessary, high-pressure balloon dilation is performed to minimize residual stenosis. The procedure is performed as follows: 1. Select the optimal projection angle providing the best view of the lesion. 2. Provide sufficient nitroglycerin for vasodilation. If the lesion is severely stenotic, perform balloon angioplasty, followed by nitroglycerin supply. 3. Perform OCT to obtain pre-procedural images of the vessel. If there is a stenosis and OCT images cannot be obtained, perform OCT after adequate balloon angioplasty. 4. Determine the length and size of the stent to be implanted according to the OCT images. Select the stent size in consideration of the mean lumen diameter and mean external elastic lamina (EEL) diameter of the distal reference vessel. If the EEL is not observed, use a stent that is 0.25 mm larger than the mean lumen diameter. Select the length by measuring the length of the proximal and distal reference vessel segments on the OCT. 5. Perform high-pressure balloon dilation after stent implantation. Select the final balloon size by considering the inside diameters of the distal and proximal reference vessels and EEL diameter. 6. Perform OCT. If no procedure-related complications are observed and there is no underexpansion or malapposition of the stent, perform a final coronary angiogram. If procedure-related complications or underexpansion or malapposition of the stent is observed, correct it, and then perform a final OCT to measure the stent area (mm2), the primary efficacy endpoint.

Interventions

OTHERIntervention Procedure: PCI

Percutaneous Coronary Intervention

Sponsors

Korea Medical Device Development Fund
CollaboratorUNKNOWN
Medipixel,Inc
CollaboratorUNKNOWN
Asan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men or women at least 19 years of age * Patients with typical symptoms or objective evidence of myocardial ischemia and eligible for coronary angioplasty. * Subject with severe coronary artery disease undergoing PCI * Written informed consent

Exclusion criteria

* Angiographic

Design outcomes

Primary

MeasureTime frameDescription
Minimal Stent Area evaluated by OCT1hourMinimal Stent Area evaluated by OCT after stenting of the target lesion
Procedural complications24hoursProcedural complications including angiographic dissection, perforation, or acute closure requiring active intervention after stent implantation

Secondary

MeasureTime frameDescription
Angiographic endpoint24hoursMinimal lumen diameter at the stented segment, diameter stenosis at the stented segment, acute gain at the stented segment
Death6monthAll-cause death , Cardiac and non-Cardiac death
MI6monthAny MI( periprocedural/spontaneous MI), Target vessel-MI and non-target vessel-MI
Stent thrombosis6monthdefinite/probable
Procedural success24hoursStent expansion (≥ 90%) in final OCT assessment and successful stent delivery without target-lesion failure in 24 hours
Composite of event6monthComposite of all-cause death, myocardial infarction, stent thrombosis, or revascularization
Quality of life score assessed by the EQ-5D6monthThe EQ-5D-5L essentially consists of 2 pages: the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS).The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. EQ-5D: the minimum and maximum values are 5 and 25 respectively. EQ VAS: the minimum and maximum values are 0 and 100 respectively.
Quality of life score assessed by Health-related Quality of Life Instrument with 8 Items (HINT-8)6monthHINT-8 was developed based on 4 health dimensions: physical, mental, social, and positive health dimensions. It consists of climbing stairs, endurance to pain, vitality, working, depression, memory, sleep, and happiness.
Cost-effective analysis6monthCost-effective analysis based on average treatment costs for two treatment
Revascularization6monthAny revascularization,Target vessel and target lesion revascularization
OCT endpoint24hoursStent expansion, stent malapposition, intra-stent tissue (plaque or thrombus) protrusion, untreated reference segment disease

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026